The emergence of novel psychoactive substances offers a unique opportunity for researchers and policymakers alike. Among these, 2-FDCK has gained prominence as a potent dissociative agent with uncertain pharmacological properties. Preliminary studies suggest that 2-FDCK may produce comparable effects to other dissociatives, such as ketamine, but it